论文部分内容阅读
目的:评价武汉市32家医院银杏叶制剂的应用情况和趋势。方法:对2009～2011年武汉市32家医院银杏叶制剂的用药总金额和用药频度(DDDs)进行统计分析。结果:2009～2011年银杏叶制剂的用药总金额及DDDs呈逐年平稳上升的趋势;口服剂型的用药金额和DDDs逐年上升,而注射剂型用药金额及构成比和DDDs从2011年开始出现下降趋势。结论:银杏叶制剂口服剂型仍然为武汉市临床应用的主导剂型。随着药品性价比的提高和人口老龄化进程的加快,银杏叶制剂市场将进一步扩大
Objective: To evaluate the application and trend of Ginkgo biloba preparations in 32 hospitals in Wuhan. Methods: The total amount of medication and DDDs of ginkgo leaf preparations in 32 hospitals in Wuhan from 2009 to 2011 were statistically analyzed. Results: The total dosage and DDDs of Ginkgo biloba preparations tended to increase steadily year by year from 2009 to 2011. The dosage and DDDs of oral dosage forms increased year by year. However, the amounts and composition of DDDs and the dosage of DDDs decreased from 2011 onwards. Conclusion: The oral dosage form of Ginkgo biloba preparation is still the predominant dosage form for clinical application in Wuhan. With the cost-effective drugs and the aging population accelerated, Ginkgo biloba preparations market will be further expanded